These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7691442)
1. Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies. Yu H; Diamandis EP Clin Chem; 1993 Oct; 39(10):2108-14. PubMed ID: 7691442 [TBL] [Abstract][Full Text] [Related]
2. Double-label time-resolved immunofluorometric assay of prostate-specific antigen and of its complex with alpha 1-antichymotrypsin. Leinonen J; Lövgren T; Vornanen T; Stenman UH Clin Chem; 1993 Oct; 39(10):2098-103. PubMed ID: 7691441 [TBL] [Abstract][Full Text] [Related]
3. Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Ferguson RA; Yu H; Kalyvas M; Zammit S; Diamandis EP Clin Chem; 1996 May; 42(5):675-84. PubMed ID: 8653891 [TBL] [Abstract][Full Text] [Related]
4. Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen. Stamey TA; Graves HC; Wehner N; Ferrari M; Freiha FS J Urol; 1993 Apr; 149(4):787-92. PubMed ID: 7681119 [TBL] [Abstract][Full Text] [Related]
5. The use of 'ultrasensitive' prostate-specific antigen assays in the detection of biochemical recurrence after radical prostatectomy. van Iersel MP; Thomas CM; Segers MF; Witjes WP; Debruyne FM; Oosterhof GO Br J Urol; 1996 Mar; 77(3):418-22. PubMed ID: 8814849 [TBL] [Abstract][Full Text] [Related]
6. Ultrasensitive assay of prostate-specific antigen used for early detection of prostate cancer relapse and estimation of tumor-doubling time after radical prostatectomy. Yu H; Diamandis EP; Prestigiacomo AF; Stamey TA Clin Chem; 1995 Mar; 41(3):430-4. PubMed ID: 7533672 [TBL] [Abstract][Full Text] [Related]
7. Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum. Piironen T; Lövgren J; Karp M; Eerola R; Lundwall A; Dowell B; Lövgren T; Lilja H; Pettersson K Clin Chem; 1996 Jul; 42(7):1034-41. PubMed ID: 8674186 [TBL] [Abstract][Full Text] [Related]
8. Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique. Yu H; Diamandis EP J Urol; 1995 Mar; 153(3 Pt 2):1004-8. PubMed ID: 7531781 [TBL] [Abstract][Full Text] [Related]
9. Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay. Ellis WJ; Vessella RL; Noteboom JL; Lange PH; Wolfert RL; Rittenhouse HG Urology; 1997 Oct; 50(4):573-9. PubMed ID: 9338734 [TBL] [Abstract][Full Text] [Related]
11. Detection of prostate cancer relapse with prostate specific antigen monitoring at levels of 0.001 to 0.1 microG./L. Yu H; Diamandis EP; Wong PY; Nam R; Trachtenberg J J Urol; 1997 Mar; 157(3):913-8. PubMed ID: 9072598 [TBL] [Abstract][Full Text] [Related]
12. Zeptomole detection sensitivity of prostate-specific antigen in a rapid microtitre plate assay using time-resolved fluorescence. Härmä H; Soukka T; Lönnberg S; Paukkunen J; Tarkkinen P; Lövgren T Luminescence; 2000; 15(6):351-5. PubMed ID: 11114110 [TBL] [Abstract][Full Text] [Related]
13. Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer. Schambeck CM; Schmeller N; Stieber P; Jansen HM; Pahl H; Schneider W; Fateh-Moghadam A Urology; 1995 Aug; 46(2):195-9. PubMed ID: 7542821 [TBL] [Abstract][Full Text] [Related]
15. Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy. Haese A; Huland E; Graefen M; Hammerer P; Noldus J; Huland H J Urol; 1999 Apr; 161(4):1206-11. PubMed ID: 10081870 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of the nadir value of serum prostate-specific antigen measured by an ultrasensitive assay as a predictor of biochemical recurrence after radical prostatectomy for clinically localized prostate cancer. Sakai I; Harada K; Kurahashi T; Muramaki M; Yamanaka K; Hara I; Inoue TA; Miyake H Urol Int; 2006; 76(3):227-31. PubMed ID: 16601384 [TBL] [Abstract][Full Text] [Related]
17. Sensitive prostate specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy. Witherspoon LR; Lapeyrolerie T J Urol; 1997 Apr; 157(4):1322-8. PubMed ID: 9120931 [TBL] [Abstract][Full Text] [Related]
18. Development of sensitive immunoassays for free and total human glandular kallikrein 2. Väisänen V; Eriksson S; Ivaska KK; Lilja H; Nurmi M; Pettersson K Clin Chem; 2004 Sep; 50(9):1607-17. PubMed ID: 15247158 [TBL] [Abstract][Full Text] [Related]
19. Dual-label time-resolved immunofluorometric assay of free and total prostate-specific antigen based on recombinant Fab fragments. Eriksson S; Vehniäinen M; Jansén T; Meretoja V; Saviranta P; Pettersson K; Lövgren T Clin Chem; 2000 May; 46(5):658-66. PubMed ID: 10794748 [TBL] [Abstract][Full Text] [Related]